自然存在的甲和甲:具有抗疟疾潜力
Usama Ramadan Abdelmohsen1,2, Soad A L Bayoumi3, Nesma M Mohamed3,4
1Department of Pharmacognosy, Faculty of Pharmacy, Minia University Minia 61519 Egypt usama.ramadan@mu.edu.eg.
新的研究探索了用于治疗疟疾的天然化合物. 烯胺和腺素素显示出作为潜在的抗疟疾药物对抗Plasmodium falciparum的承诺,为药物开发提供了新的线索.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 疟疾仍然是一个重要的全球健康威胁,由寄生虫杆菌引起.
- 由于新出现的耐药性,对新型抗疟疾药物的需求非常大.
- 自然产品是识别新生物活性化合物的宝贵资源.
研究的目的:
- 研究自然存在的烯和乙的抗疟疾潜力.
- 确定有希望的化学线索,用于开发新的抗疟疾疗法.
- 为了评估腺素素对抗Plasmodium falciparum的抗等离子体活性.
主要方法:
- 对于自然存在的烯和乙的结合亲和力在分析.
- 针对Plasmodium falciparum的关键目标进行计算对接:pfPK5,cyt bc1和pfKRS1.
- 在体外评估使用SYBR绿色I基光试验对腺素素的抗等离子体活性.
主要成果:
- 25种烯和乙化合物对Plasmodium falciparum目标表现出中度至强度的结合亲和力.
- 腺氨酸对P. falciparum3D7菌株的高抗疟疾活性.
- 在24小时的潜伏期后,记载了glandularin的IC50值为11.2μM.
结论:
- 烯胺和腺素素被确定为抗疟疾药物开发的有前途的化学道.
- 这项研究支持对新型抗感染剂的天然产品的探索.
- 对腺素和相关化合物的进一步研究可能会导致有效的疟疾治疗.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
09:46Synthesis of Plant Phenol-derived Polymeric Dyes for Direct or Mordant-based Hair Dyeing
Published on: December 1, 2016
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Physical Properties of Amines
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Antipsychotic Drugs: Typical and Atypical Agents
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
